EichorEICHOR
Location: Kaohsiung City Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Kaohsiung City

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Kaohsiung Medical University Chung-Ho Memorial Hospital · Eli Lilly and Company · NCT07218380This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Kaohsiung Medical University Chung-Ho Memorial Hospital · Pfizer · NCT07028853A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Chang Gung Memorial Hospital at Kaohsiung-Division of Hemato · Merck Sharp & Dohme LLC · NCT06136559This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Kaohsiung Medical University Chung-Ho Memorial Hospital · Pfizer · NCT06758401A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Kaohsiung Medical University Chung-Ho Memorial Hospital · Hoffmann-La Roche · NCT06793215Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Kaohsiung Medical University Chung-Ho Memorial Hospital · Amgen · NCT07037433LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Kaohsiung Medical University Chung-Ho Memorial Hospital · Eli Lilly and Company · NCT07415044Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Kaohsiung Medical University Chung-Ho Memorial Hospital · Eli Lilly and Company · NCT06890598A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · Kaohsiung Veterans General Hospital · Bayer · NCT07192952A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Kaohsiung Medical University Chung-Ho Memorial Hospital · Pfizer · NCT07144280Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Kaohsiung Medical University Hospital · Gilead Sciences · NCT06051617EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · E-Da Hospital · Boehringer Ingelheim · NCT06531824A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Kaohsiung Medical University Chung-Ho Memorial Hospital · Biogen · NCT06962800A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Kaohsiung Chang Gung Memorial Hospital · Boehringer Ingelheim · NCT07220083Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · Eli Lilly and Company · NCT07353931A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · Kaohsiung Medical University - Chung-Ho Memorial Hospital · Takeda · NCT06963827A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · E-DA Cancer Hospital /ID# 239718 · AbbVie · NCT04928846Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop
Phase 3 · Kaohsiung Chang Gung Memorial Hospital · Daiichi Sankyo · NCT06731478A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Kaohsiung Medical University Chung-Ho Memorial Hospital · Pfizer · NCT06629779A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of C
Phase 3 · E-Da Cancer Hospital /ID# 279745 · AbbVie · NCT07525206A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Bristol-Myers Squibb · NCT06561386A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Phase 2 · Kaohsiung Veterans General Hospital ( Site 2905) · Merck Sharp & Dohme LLC · NCT07133633DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carbop
Phase 3 · Kaohsiung Medical University Chung-Ho Memorial Hospital · Boehringer Ingelheim · NCT07472517A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type
Phase 3 · Kaohsiung Medical University Chung-Ho Memorial Hospital · Hoffmann-La Roche · NCT07351058A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
Phase 3 · Kaohsiung Medical University Chung-Ho Memorial Hospital · Dimerix Bioscience Pty Ltd · NCT05183646Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Phase 3 · Kaohsiung Medical University Chung-Ho Memorial Hospital · Eli Lilly and Company · NCT07223593A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Phase 2 · Kaohsiung Medical University Chung-Ho Memorial Hospital · Karyopharm Therapeutics Inc · NCT05980806A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurre
Phase 3 · Kaohsiung Medical University Chung-Ho Memorial Hospital · Rakuten Medical, Inc. · NCT06699212Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
Phase 2 · E-Da Cancer Treatment Hospital · Lukas Biomedical Inc. · NCT05304481Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Im
Phase 1/Phase 2 · Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# · AbbVie · NCT06772623
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.